Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals
 


  Biotechnology Law Report
  Volume 26, Number 5, October 2007
  homepage                   other issues
 

  • Editorial
  • Automated Patent Examination Support—A Proposal
        Gerry J. Elman
        p.435-436                                                                              +cite        

  • Paper
  • Chemical and Biotechnology Obviousness in a State of Flux
        Harold C. Wegner
        p.437-462                                                                              +cite        

  • Expert Analysis of Current Developments
  • Biosimilars in the United States; A Brief Look at Where We Are and the Road Ahead
        Alan J. Morrison
        p.463-468                                                                              +cite        

  • Regulatory Affairs—Pharmaceutical
  • Majority Upholds Restrictions on Access to Experimental Drugs; Death in Gene Therapy Trial Was Caused by Histoplasmosis
        p.469-474                                                                              +cite    

  • Regulatory Affairs—Agricultural and Environmental
  • Genetically Modified Plants Eaten by Animals Do Not Affect Their Meat or Other Products; USDA Permits Planting of Human Protein-Producing Rice Strain; APHIS Proposes Extensive Regulatory Changes; USDA Allows Planting of Antibody-Producing Tobacco
        p.475-476                                                                              +cite    

  • Patents
  • PTO Agrees to Review Patents on Anti-HIV Drug; Canadian Decision May or May Not Have Profound Implications; PTO Strives to Get a Handle on Markush Claim; CAFC Agrees Patent Law Preempts D.C. Price-Control Measure
        p.477-480                                                                              +cite    

  • Patent Litigation
  • Scripps and Merck Did Not Infringe; More Markman Rulings in Erythropoietin Litigation?; Markman Ruling in Digene-Third Wave Suit May Strengthen Latter's Position; Beckman Coulter Dismissed from Suit over HPV Intellectual Property Rights; FeBit and Codon Sue Each Other over Method of Making Synthetic Nucleic Acids
        p.481-488                                                                              +cite    

  • Scientific Misconduct
  • Science Paper on Embryo Asymmetry Retracted
        p.489-490                                                                              +cite    
  • On the Move
        p.491-492                                                                              +cite    

  • Texts
  • Abigail Alliance for Better Access to Developmental Drugs and Washington Legal Foundation v. Andrew von Eschenbach and Michael O. Leavitt (No. 03cv01601)
        p.493-514                                                                              +cite    
  • Introduction of Organisms and Products Altered or Produced Through Genetic Engineering
        p.515-520                                                                              +cite    
  • Finding of No Significant Impact (APHIS Permit 05-354-01r)
        p.521-522                                                                              +cite    
  • Examination of Patent Applications That Include Claims Containing Alternative Language
        p.523-536                                                                              +cite    
  • Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America v. District of Columbia et al. (2006-1593)
        p.537-544                                                                              +cite    
  • Integra Lifesciences I, Ltd. and The Burnham Institute and Telios Pharmaceuticals, Inc. v. Merck KGaA and The Scripps Research Institute and Dr. David A. Cheresh (2002-1052, -1065)
        p.545-558                                                                              +cite    
  • Amgen, Inc. v. F. Hoffmann-La Roche Ltd., Roche Diagnostics GmbH, and Hoffmann-La Roche Inc. (No. 05-12237-WGY)
        p.559-570                                                                              +cite    
  • Coming Events
        p.571-574                                                                              +cite